Cohen L M, McCue J D, Germain M, Kjellstrand C M
Department of Psychiatry, Tufts University School of Medicine, Boston, MA.
Arch Intern Med. 1995 Jan 9;155(1):42-7.
Approximately 10% of the deaths of patients receiving long-term dialysis for end-stage renal disease are preceded by discontinuation of dialysis. We prospectively studied the decision to discontinue dialysis and whether, as is often stated, these patients have a prompt, predictable, and comfortable death.
All patients receiving hemodialysis in a hospital-based and a freestanding unit whose long-term dialysis was discontinued in 1990 were included in the study. Patients, providers, and families of prospectively enrolled cases were interviewed to determine the reasons for discontinuation; the patients' terminal courses were reviewed daily to collect information describing their quality of death. Retrospectively enrolled cases were studied by chart review and interviews of providers. The reasons for discontinuation of dialysis and a rating of the quality of their deaths (for prospectively studied patients only) were determined by interdisciplinary team consensus. Quality of death was rated on scales of 1 (worst) to 5 (best) according to duration of dying, discomfort, and psychosocial circumstances.
Eighteen patients discontinued dialysis after a mean duration of 43.6 months of hemodialysis, and they lived a mean of 9.6 days after termination. The quality of death of the 11 patients who were enrolled prospectively was subjectively assessed as "good" (> 10 of a possible 15 points) for seven patients and "poor" for four patients. A good quality of death was more likely if dialysis was discontinued because of medical deterioration from progressive chronic disease (P = .009); none of the three patients whose dialysis was discontinued for other reasons had a good death (P = .024).
A majority of the prospective cohort of patients who discontinued dialysis experienced a good death by our largely subjective criteria. Improved palliative therapy for some of these dying patients, however, could have ameliorated prolonged suffering, delirium, and inadequately treated pain that led to a poor quality of death.
在接受长期透析治疗的终末期肾病患者中,约10%的死亡发生在透析中断之后。我们对停止透析的决定进行了前瞻性研究,以及这些患者是否如通常所说的那样,能有迅速、可预测且舒适的死亡过程。
研究纳入了1990年在一家医院透析中心和一家独立透析单位接受血液透析且长期透析被中断的所有患者。对前瞻性纳入病例的患者、医护人员和家属进行访谈,以确定中断透析的原因;每天回顾患者的终末期病程,收集描述其死亡质量的信息。通过病历审查和对医护人员的访谈对回顾性纳入病例进行研究。透析中断的原因以及对其死亡质量的评分(仅针对前瞻性研究的患者)由多学科团队达成共识确定。根据死亡持续时间、不适程度和社会心理状况,将死亡质量评为1分(最差)至5分(最佳)。
18例患者在平均43.6个月的血液透析后停止透析,停止透析后平均存活9.6天。前瞻性纳入的11例患者中,7例患者的死亡质量主观评估为“良好”(可能的15分中>10分),4例患者为“差”。如果因进行性慢性病导致的医疗状况恶化而停止透析,则更有可能有良好的死亡质量(P = 0.009);因其他原因停止透析的3例患者中,无一例有良好的死亡质量(P = 0.024)。
根据我们主要是主观的标准,大多数停止透析的前瞻性队列患者经历了良好的死亡过程。然而,对其中一些临终患者改善姑息治疗,本可缓解导致死亡质量差的长期痛苦、谵妄和疼痛治疗不足的情况。